세계의 항균제 내성 감시 시장 보고서(2025년)

Antimicrobial Resistance Surveillance Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

항균제 내성 감시 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 항균제 내성에 대한 인식 증가, 진단 기술의 발전, 정부 이니셔티브 및 자금 지원 증가, 의료 관련 감염의 급증, 새로운 항생제 및 대체 치료법의 개발 등에 기인할 수 있습니다.

감염의 유행 증가는 항균제 내성 감시 시장의 성장을 가속할 것으로 예측됩니다. 기후 변화, 도시화, 세계여행 등의 요인은 병원체의 감염을 촉진하고 새로운 미생물에 인간이 노출되는 기회를 늘림으로써 이러한 질병의 유병률의 상승에 기여하고 있습니다. 원체의 만연을 추적하고 효과적인 치료 전략을 이끌고 감염증과 싸우기 위한 공중위생 정책을 형성하는데 있어서 매우 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월 영국 보건안전국의 보고서에 따르면 영국에서 결핵(TB) 사례가 2022년 4,380건에서 2023년 4,850건으로 10.7% 증가했다고 합니다.

업계의 주요 기업은 효율 개선, 정밀도 향상, 비용 절감, 환자 결과 개선을 위한 첨단 진단 툴 등의 혁신적인 기술에 주력하고 있습니다. 예를 들어, 2023년 6월 스웨덴에 본사를 둔 진단 제품 제조업체인 시스멕스 아스트레고 AB는 PA-100 AST 현장 진단 검사 시스템을 출시했습니다. 이 시스템은 항균제 내성을 현장로 신속하고 정확하게 검출할 수 있게 해, 며칠이 소요되는 종래의 검사법에 비해, 결과가 나올 때까지의 시간을 대폭 단축합니다. 30분 안에 결과를 얻을 수 있기 때문에 임상의는 전염병 치료와 관련하여 적시에 충분한 정보를 바탕으로 결정을 내릴 수 있으며 광역 항생제에 대한 의존도를 최소화하고 항균제 내성을 억제하는 노력에 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 항균제 내성 감시 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 항균제 내성 감시 시장 : 성장률 분석
• 세계의 항균제 내성 감시 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 항균제 내성 감시 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 항균제 내성 감시 전체 시장(TAM)

제6장 시장 세분화

• 세계의 항균제 내성 감시 시장 : 솔루션별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 진단 키트
• 진단 시스템
• 감시 소프트웨어
• 서비스
• 세계의 항균제 내성 감시 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 임상 진단
• 공중 보건 감시
• 기타 용도
• 세계의 항균제 내성 감시 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 및 진료소
• 연구 및 학술기관
• 기타 최종 사용자
• 세계의 항균제 내성 감시 시장 : 진단 키트 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• PCR 키트
• 면역 분석 키트
• 측면 유량 분석 키트
• 세계의 항균제 내성 감시 시장 : 진단 시스템 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 자동 감수성 검사 시스템
• 전체 게놈 염기서열 분석(WGS) 시스템
• 질량 분석 기반 시스템
• 세계의 항균제 내성 감시 시장 : 감시 소프트웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 클라우드 기반 감시 플랫폼
• AI 기반 데이터 분석 도구
• 전자건강기록(EHR)-통합시스템
• 세계의 항균제 내성 감시 시장 : 서비스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 실험실 시험 서비스
• 데이터 관리 및 보고 서비스
• 컨설팅 및 교육 서비스

제7장 지역별/국가별 분석

• 세계의 항균제 내성 감시 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 항균제 내성 감시 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 항균제 내성 감시 시장 : 경쟁 구도
• 항균제 내성 감시 시장 : 기업 프로파일
  • Roche Diagnostics 개요, 제품 및 서비스, 전략 및 재무 분석
  • Thermo Fisher Scientific Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Abbott Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
  • Danaher Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
  • Becton, Dickinson and Company 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Viatris Inc.
• Wolters Kluwer NV
• Hologic Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen NV
• Cepheid Inc.
• Shionogi & Co. Ltd.
• Venatorx Pharmaceuticals Inc.
• Accelerate Diagnostics Inc.
• Paratek Pharmaceuticals Inc.
• Liofilchem Srl
• Lumed Inc.
• OpGen Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 항균제 내성 감시 시장(2029년) : 새로운 기회를 제공하는 국가
• 항균제 내성 감시 시장(2029년) : 새로운 기회를 제공하는 부문
• 항균제 내성 감시 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Antimicrobial resistance (AMR) surveillance involves the systematic monitoring and tracking of antimicrobial-resistant microorganisms to detect emerging resistance patterns, guide public health interventions, and inform treatment strategies for infections caused by resistant bacteria, viruses, and fungi.

The primary solutions in AMR surveillance include diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are pre-packaged tools that enable healthcare professionals to rapidly identify antimicrobial-resistant infections in patients. These solutions are applied in clinical diagnostics, public health surveillance, and other areas, serving end users such as hospitals and clinics, research and academic institutes, and other healthcare facilities.

The antimicrobial resistance surveillance market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance surveillance market statistics, including antimicrobial resistance surveillance industry global market size, regional shares, competitors with an antimicrobial resistance surveillance market share, detailed antimicrobial resistance surveillance market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance surveillance industry. This antimicrobial resistance surveillance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the increased use of antibiotics in agriculture, the overprescription of antibiotics in healthcare, a lack of diagnostic testing, inadequate infection prevention and control practices, and the impact of global travel and trade.

The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing awareness of antimicrobial resistance, advancements in diagnostic technologies, rising government initiatives and funding, a surge in healthcare-associated infections, and the development of new antibiotics and alternative treatments. Key trends include the use of artificial intelligence for data analysis, next-generation sequencing technologies, real-time surveillance systems, molecular diagnostic tools, and the integration of big data and machine learning for predictive modeling.

The increasing prevalence of infectious diseases is expected to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly between individuals. Factors such as climate change, urbanization, and global travel contribute to the rising prevalence of these diseases by facilitating pathogen transmission and increasing human exposure to new microbes. Antimicrobial resistance surveillance plays a crucial role in tracking the spread of resistant pathogens, guiding effective treatment strategies, and shaping public health policies to combat infectious diseases. For example, in February 2024, a report by the UK Health Security Agency revealed a 10.7% increase in tuberculosis (TB) cases in England, with 4,850 cases reported in 2023 compared to 4,380 in 2022. As a result, the increasing prevalence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.

Leading companies in the industry are focusing on innovative technologies, such as advanced diagnostic tools, to improve efficiency, enhance accuracy, reduce costs, and provide better patient outcomes. A diagnostic tool encompasses any device, instrument, software, or methodology used to detect, identify, or assess the presence of a condition, disease, or malfunction. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer of diagnostic products, launched the PA-100 AST Point-of-Care Testing System. This system enables rapid and precise detection of antimicrobial resistance at the point of care, significantly reducing the time required for results compared to conventional laboratory methods, which can take several days. By delivering results in just 30 minutes, it empowers clinicians to make timely and informed decisions regarding infection treatment, minimizing reliance on broad-spectrum antibiotics and aiding efforts to curb antimicrobial resistance.

In January 2024, BioMerieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. This acquisition is aimed at enhancing BioMerieux's capabilities in combating antimicrobial resistance and strengthening its portfolio, particularly by offering digital tools to support antibiotic stewardship. LUMED Inc., an Italy-based company, specializes in healthcare and medical data analysis, with a focus on antimicrobial resistance surveillance.

Major players in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.

North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance surveillance report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial resistance surveillance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Resistance Surveillance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial resistance surveillance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial resistance surveillance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antimicrobial resistance surveillance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
• 2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
• 3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
• Subsegments:
• 1) By Diagnostic Kits: PCR-Based Kits; Immunoassay Kits; Lateral Flow Assay Kits
• 2) By Diagnostic Systems: Automated Susceptibility Testing Systems; Whole Genome Sequencing (WGS) Systems; Mass Spectrometry-Based Systems
• 3) By Surveillance Software: Cloud-Based Surveillance Platforms; AI-Powered Data Analytics Tools; Electronic Health Record (EHR)-Integrated Systems
• 4) By Services: Laboratory Testing Services; Data Management & Reporting Services; Consultation & Training Services
• Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antimicrobial Resistance Surveillance Market Characteristics

3. Antimicrobial Resistance Surveillance Market Trends And Strategies

4. Antimicrobial Resistance Surveillance Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Antimicrobial Resistance Surveillance Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antimicrobial Resistance Surveillance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antimicrobial Resistance Surveillance Market Growth Rate Analysis
• 5.4. Global Antimicrobial Resistance Surveillance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antimicrobial Resistance Surveillance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antimicrobial Resistance Surveillance Total Addressable Market (TAM)

6. Antimicrobial Resistance Surveillance Market Segmentation

• 6.1. Global Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Kits
• Diagnostic Systems
• Surveillance Software
• Services
• 6.2. Global Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Diagnostics
• Public Health Surveillance
• Other Applications
• 6.3. Global Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research And Academic Institutes
• Other End Users
• 6.4. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR-Based Kits
• Immunoassay Kits
• Lateral Flow Assay Kits
• 6.5. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Susceptibility Testing Systems
• Whole Genome Sequencing (WGS) Systems
• Mass Spectrometry-Based Systems
• 6.6. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Surveillance Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Surveillance Platforms
• AI-Powered Data Analytics Tools
• Electronic Health Record (EHR)-Integrated Systems
• 6.7. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing Services
• Data Management And Reporting Services
• Consultation And Training Services

7. Antimicrobial Resistance Surveillance Market Regional And Country Analysis

• 7.1. Global Antimicrobial Resistance Surveillance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antimicrobial Resistance Surveillance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Resistance Surveillance Market

• 8.1. Asia-Pacific Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Resistance Surveillance Market

• 9.1. China Antimicrobial Resistance Surveillance Market Overview
• 9.2. China Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Resistance Surveillance Market

• 10.1. India Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Resistance Surveillance Market

• 11.1. Japan Antimicrobial Resistance Surveillance Market Overview
• 11.2. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Resistance Surveillance Market

• 12.1. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Resistance Surveillance Market

• 13.1. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Resistance Surveillance Market

• 14.1. South Korea Antimicrobial Resistance Surveillance Market Overview
• 14.2. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Resistance Surveillance Market

• 15.1. Western Europe Antimicrobial Resistance Surveillance Market Overview
• 15.2. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Resistance Surveillance Market

• 16.1. UK Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Resistance Surveillance Market

• 17.1. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Resistance Surveillance Market

• 18.1. France Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Resistance Surveillance Market

• 19.1. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Resistance Surveillance Market

• 20.1. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Resistance Surveillance Market

• 21.1. Eastern Europe Antimicrobial Resistance Surveillance Market Overview
• 21.2. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Resistance Surveillance Market

• 22.1. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Resistance Surveillance Market

• 23.1. North America Antimicrobial Resistance Surveillance Market Overview
• 23.2. North America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Resistance Surveillance Market

• 24.1. USA Antimicrobial Resistance Surveillance Market Overview
• 24.2. USA Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Resistance Surveillance Market

• 25.1. Canada Antimicrobial Resistance Surveillance Market Overview
• 25.2. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Resistance Surveillance Market

• 26.1. South America Antimicrobial Resistance Surveillance Market Overview
• 26.2. South America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Resistance Surveillance Market

• 27.1. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Resistance Surveillance Market

• 28.1. Middle East Antimicrobial Resistance Surveillance Market Overview
• 28.2. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Resistance Surveillance Market

• 29.1. Africa Antimicrobial Resistance Surveillance Market Overview
• 29.2. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Resistance Surveillance Market Competitive Landscape And Company Profiles

• 30.1. Antimicrobial Resistance Surveillance Market Competitive Landscape
• 30.2. Antimicrobial Resistance Surveillance Market Company Profiles
  • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Resistance Surveillance Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Wolters Kluwer NV
• 31.3. Hologic Inc.
• 31.4. Biomerieux SA
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Bruker Corporation
• 31.7. Qiagen NV
• 31.8. Cepheid Inc.
• 31.9. Shionogi & Co. Ltd.
• 31.10. Venatorx Pharmaceuticals Inc.
• 31.11. Accelerate Diagnostics Inc.
• 31.12. Paratek Pharmaceuticals Inc.
• 31.13. Liofilchem Srl
• 31.14. Lumed Inc.
• 31.15. OpGen Inc.

32. Global Antimicrobial Resistance Surveillance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Resistance Surveillance Market

34. Recent Developments In The Antimicrobial Resistance Surveillance Market

35. Antimicrobial Resistance Surveillance Market High Potential Countries, Segments and Strategies

• 35.1 Antimicrobial Resistance Surveillance Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antimicrobial Resistance Surveillance Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antimicrobial Resistance Surveillance Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료